Nra Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 01-11-2024
- Paid Up Capital ₹ 0.10 M
as on 01-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.09 Cr
as on 01-11-2024
- Revenue 78.24%
(FY 2023)
- Profit 4.14%
(FY 2023)
- Ebitda -0.75%
(FY 2023)
- Net Worth 85.79%
(FY 2023)
- Total Assets 51.63%
(FY 2023)
About Nra Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.09 Cr.
Peerasan Fathima and Valarmathi Niveditha serve as directors at the Company.
- CIN/LLPIN
U85300TN2020PTC136734
- Company No.
136734
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nra Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Peerasan Fathima  | Director | 29-Jul-2020 | Current |
| Valarmathi Niveditha | Director | 29-Jul-2020 | Current |
Financial Performance of Nra Healthcare.
Nra Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.24% increase. The company also saw a slight improvement in profitability, with a 4.14% increase in profit. The company's net worth Soared by an impressive increase of 85.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nra Healthcare?
Unlock access to Nra Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Fetolink Healthcare Private LimitedActive 23 daysPeerasan Fathima and Valarmathi Niveditha are mutual person
- Aquila Diagnostic Services Private LimitedActive 22 days
Peerasan Fathima and Valarmathi Niveditha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Apr 2022 | ₹3.80 M | Open |
Others Creation Date: 27 Oct 2021 | ₹7.10 M | Open |
How Many Employees Work at Nra Healthcare?
Unlock and access historical data on people associated with Nra Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nra Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nra Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
